PL2029740T3 - Zastosowanie polisacharydów do promowania aktywności enzymatycznej - Google Patents

Zastosowanie polisacharydów do promowania aktywności enzymatycznej

Info

Publication number
PL2029740T3
PL2029740T3 PL06760588T PL06760588T PL2029740T3 PL 2029740 T3 PL2029740 T3 PL 2029740T3 PL 06760588 T PL06760588 T PL 06760588T PL 06760588 T PL06760588 T PL 06760588T PL 2029740 T3 PL2029740 T3 PL 2029740T3
Authority
PL
Poland
Prior art keywords
polysaccharides
promotion
enzymatic activity
enzymatic
activity
Prior art date
Application number
PL06760588T
Other languages
English (en)
Inventor
Frank Riske
Michael Hayes
Gary Lazarus
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of PL2029740T3 publication Critical patent/PL2029740T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/08—Ethers
    • C08B31/12—Ethers having alkyl or cycloalkyl radicals substituted by heteroatoms, e.g. hydroxyalkyl or carboxyalkyl starch
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01052—Beta-N-acetylhexosaminidase (3.2.1.52)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0102—Alpha-glucosidase (3.2.1.20)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01045—Glucosylceramidase (3.2.1.45), i.e. beta-glucocerebrosidase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL06760588T 2006-05-31 2006-05-31 Zastosowanie polisacharydów do promowania aktywności enzymatycznej PL2029740T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06760588A EP2029740B1 (en) 2006-05-31 2006-05-31 Use of polysaccharides for promotion of enzymatic activity
PCT/US2006/021092 WO2007139553A1 (en) 2006-05-31 2006-05-31 Use of polysaccharides for promotion of enzymatic activity

Publications (1)

Publication Number Publication Date
PL2029740T3 true PL2029740T3 (pl) 2012-11-30

Family

ID=37745607

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06760588T PL2029740T3 (pl) 2006-05-31 2006-05-31 Zastosowanie polisacharydów do promowania aktywności enzymatycznej

Country Status (7)

Country Link
US (2) US9175283B2 (pl)
EP (1) EP2029740B1 (pl)
JP (1) JP5094850B2 (pl)
ES (1) ES2386972T3 (pl)
PL (1) PL2029740T3 (pl)
PT (1) PT2029740E (pl)
WO (1) WO2007139553A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2029740B1 (en) 2006-05-31 2012-06-20 Genzyme Corporation Use of polysaccharides for promotion of enzymatic activity
RU2418608C1 (ru) * 2007-06-26 2011-05-20 Филлигент Лимитед Устройства и способы уменьшения передачи микроорганизмов, патогенных для человека
JPWO2011037058A1 (ja) * 2009-09-22 2013-02-21 天野エンザイム株式会社 ラクターゼ剤
CN104807998B (zh) * 2015-05-12 2017-01-11 先思达（南京）生物科技有限公司 一种早期肝癌诊断试剂盒及其使用方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR504653A (fr) 1918-04-19 1920-07-12 Schneider & Cie Système de liaison entre l'affut et les chariots de chenilles pour matériels d'artillerie à flèche sur chaines sans fin
US3937821A (en) 1971-08-21 1976-02-10 Kyorin Seiyaku Kabushiki Kaisha Plasma substitute including artificial starch and method for the preparation thereof
DE2615844A1 (de) * 1976-04-10 1977-10-20 Knoll Ag Fibrinogen spaltendes enzymsystem
JPS5470419A (en) * 1977-11-16 1979-06-06 Wakamoto Pharma Co Ltd Stable urokinase powdery preparaton
US4473552A (en) 1981-03-16 1984-09-25 Jost Leonora I Anaerobic method for preserving whole blood, tissue and components containing living mammalian cells
ATE66616T1 (de) 1982-08-30 1991-09-15 Baxter Int Verfahren zur herstellung von gamma-globulin enthaltenden zusammensetzungen.
EP0150067A3 (en) 1984-01-23 1986-12-30 Takeda Chemical Industries, Ltd. Stable composition of gamma-interferon
JPS60155136A (ja) 1984-01-23 1985-08-15 Takeda Chem Ind Ltd γ型インタ−フエロン組成物
DE3687255T2 (de) 1985-09-10 1993-05-06 Eisai Co Ltd Einen gewebe-plasminogen-aktivator enthaltende zusammensetzung.
US6007978A (en) 1988-05-18 1999-12-28 Cobe Laboratories, Inc. Method of freezing cells and cell-like materials
US6451600B1 (en) 1989-12-22 2002-09-17 Genzyme Corporation Enzymatically active recombinant glucocerebrosidase
US5723282A (en) 1991-07-08 1998-03-03 The American National Red Cross Method of preparing organs for vitrification
US6627275B1 (en) 1994-04-19 2003-09-30 Applied Elastomerics, Incorporated Tear resistant elastic crystal gels suitable for inflatable restraint cushions and other uses
US5616689A (en) 1994-07-13 1997-04-01 Collagen Corporation Method of controlling structure stability of collagen fibers produced form solutions or dispersions treated with sodium hydroxide for infectious agent deactivation
CA2283466A1 (en) * 1997-03-12 1998-09-17 Novo Nordisk A/S Storage-stable liquid formulation comprising a laccase
US6630137B1 (en) 1997-04-28 2003-10-07 Eli Lilly And Company Activated protein C formulations
CZ298429B6 (cs) 1997-04-28 2007-10-03 Eli Lilly And Company Stabilní lyofilizovaný prostredek
US6433161B1 (en) * 1997-04-29 2002-08-13 Hercules Incorporated Galactosylated hydroxyalkyl polysaccharides
DK1820516T3 (da) 1999-02-22 2013-10-28 Univ Connecticut Nye albuminfrie faktor VIII-præparater
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
NZ518401A (en) 1999-10-29 2004-01-30 Nektar Therapeutics Dry powder compositions having improved dispersivity
AU2352201A (en) * 1999-12-30 2001-07-16 Maxygen Aps Improved lysosomal enzymes and lysosomal enzyme activators
DK1398038T4 (da) 2000-02-08 2011-03-28 Allergan Inc Lægemidler med botulinustoxin
US7780967B2 (en) 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
DE10112825A1 (de) 2001-03-16 2002-10-02 Fresenius Kabi De Gmbh HESylierung von Wirkstoffen in wässriger Lösung
US20050169886A1 (en) * 2001-10-30 2005-08-04 Brody Richard S. Stabilization of biologically active proteins with mixtures of polysaccharides and amino acid based compounds
DE10209821A1 (de) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
US6982080B2 (en) 2002-03-15 2006-01-03 Wyeth Hydroxyethyl starch—containing polypeptide compositions
EP1877099B1 (en) * 2005-04-06 2012-09-19 Genzyme Corporation Therapeutic conjugates comprising a lysosomal enzyme, polysialic acid and a targeting moiety
EP2029740B1 (en) 2006-05-31 2012-06-20 Genzyme Corporation Use of polysaccharides for promotion of enzymatic activity
AR053507A1 (es) 2006-05-31 2007-05-09 Genzyme Corp Uso de polisacaridos para la promocion de actividad enzimatica

Also Published As

Publication number Publication date
US20160082090A1 (en) 2016-03-24
US20090263371A1 (en) 2009-10-22
EP2029740A1 (en) 2009-03-04
US9175283B2 (en) 2015-11-03
PT2029740E (pt) 2012-07-06
WO2007139553A1 (en) 2007-12-06
ES2386972T3 (es) 2012-09-10
EP2029740B1 (en) 2012-06-20
JP2009538619A (ja) 2009-11-12
JP5094850B2 (ja) 2012-12-12

Similar Documents

Publication Publication Date Title
IL232786A0 (en) Inhibitors of e1 enzyme activators
LT3225251T (lt) Proneurotrofinų veiklos moduliavimas
ZA200905363B (en) Inhibitors of AKT activity
GB0619753D0 (en) Enzyme inhibitors
SI1848718T1 (sl) Inhibitorji E1 aktivacijskih enzimov
ZA200807862B (en) Azolopyrimidines as inhibitors of cannabinoid 1 activity
PT2097457T (pt) Derivados de polissacarídeos ácidos
IL194339A0 (en) Enzyme inhibitors
EP2114388A4 (en) INHIBITORS OF AKT'S ACTIVITY
IL197714A0 (en) 2-pyridinecarboxamide derivative having gk-activating activity
IL196480A0 (en) Improvement of arginase levels/activity
EP2134175A4 (en) HAMMER OF ACT ACTIVITY
ZA200904235B (en) Method for the enantioselective enzymatic reduction of secodione derivatives
IL198803A0 (en) Selective inhibitors of neurotensin degrading enzymes
PL2029740T3 (pl) Zastosowanie polisacharydów do promowania aktywności enzymatycznej
GB0608844D0 (en) Enzyme inhibitors
EP1923402A4 (en) PROCESS FOR DETERMINING ENZYME ACTIVITY
GB0617161D0 (en) Enzyme inhibitors
IL196789A0 (en) Imino-imidazo-pyridine derivatives having antithrombotic activity
GB2467284B (en) Sulfatase enzymes
AU2010301641B2 (en) Heparanase activity inhibitor
ZA200808237B (en) Enzyme inhibitors
GB0624958D0 (en) Enzyme inhibitors
GB0620884D0 (en) Enzyme inhibitors
GB0612544D0 (en) Enzyme inhibitors